{"hands_on_practices": [{"introduction": "To begin our quantitative exploration, we will ground the complex biological process of drug excretion in a simple, intuitive physical principle. This exercise demonstrates how to calculate the rate of biliary drug excretion from two fundamental physiological parameters: the rate of bile flow ($Q_{\\text{bile}}$) and the concentration of the drug within that bile ($C_{\\text{bile}}$). By applying the principle of mass transport, you will not only compute an excretion rate but also gain insight into the primary physiological factors that the body uses to control this crucial elimination pathway [@problem_id:4940509].", "problem": "A drug undergoes hepatobiliary elimination, where excretion into bile contributes substantially to total body clearance. At steady state, bile is produced and flows from the liver to the intestine, carrying dissolved drug. Consider a patient whose bile volumetric flow rate is measured to be $Q_{\\text{bile}} = 0.8\\,\\text{ml}/\\text{min}$, and the drug concentration in bile is $C_{\\text{bile}} = 50\\,\\mu\\text{g}/\\text{ml}$. Using the conservation of mass for a solute carried by a flowing stream, first derive a general expression for the rate at which drug mass leaves the liver via bile in terms of the stream’s volumetric flow rate and solute concentration. Then, apply your derived expression to compute the biliary excretion rate for this drug with the given values. Express your final excretion rate in micrograms per minute and round your answer to four significant figures. Finally, provide a concise mechanistic interpretation of the physiological determinants of $Q_{\\text{bile}}$ and $C_{\\text{bile}}$ in terms of hepatocyte transport, bile formation, and drug physicochemical properties.", "solution": "The problem statement is evaluated for validity before attempting a solution.\n\n### Step 1: Extract Givens\n- Bile volumetric flow rate: $Q_{\\text{bile}} = 0.8\\,\\text{ml}/\\text{min}$\n- Drug concentration in bile: $C_{\\text{bile}} = 50\\,\\mu\\text{g}/\\text{ml}$\n- Task 1: Derive a general expression for the rate at which drug mass leaves the liver via bile in terms of the stream’s volumetric flow rate and solute concentration.\n- Task 2: Compute the biliary excretion rate using the given values.\n- Task 3: Express the final answer in micrograms per minute ($\\mu\\text{g}/\\text{min}$).\n- Task 4: Round the final answer to four significant figures.\n- Task 5: Provide a concise mechanistic interpretation of the physiological determinants of $Q_{\\text{bile}}$ and $C_{\\text{bile}}$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the required criteria.\n- **Scientifically Grounded**: The problem is based on the fundamental principle of mass transport in fluid dynamics, a cornerstone of chemical engineering and biotransport phenomena, and applies it to hepatobiliary drug clearance, a core topic in pharmacology and physiology. The provided values for bile flow rate ($0.8\\,\\text{ml}/\\text{min}$) and drug concentration ($50\\,\\mu\\text{g}/\\text{ml}$) are well within physiologically plausible ranges for a human.\n- **Well-Posed**: The problem is clearly structured. It asks for a derivation, a numerical calculation based on that derivation, and a mechanistic explanation. The inputs are sufficient to produce a unique answer for the quantitative parts. The qualitative part is a standard request for conceptual understanding in the field.\n- **Objective**: The problem is stated using precise, objective scientific language, free of ambiguity or subjective claims.\n- **Completeness and Consistency**: The problem is self-contained and provides all necessary information for the derivation and calculation. There are no internal contradictions. The instruction to round to four significant figures provides an explicit requirement for the final output's precision, which overrides the standard propagation of uncertainty from the input values (which have one or two significant figures as written). This is a common feature of academic problems designed to test a specific calculation and formatting ability.\n\n### Step 3: Verdict and Action\nThe problem is scientifically sound, well-posed, and objective. It is deemed **valid**. A full solution will be provided.\n\n### Solution\n\n**Part 1: Derivation of the General Expression for Biliary Excretion Rate**\n\nThe biliary excretion rate is the rate at which drug mass is transported out of the liver and into the intestine via the bile. We can denote this rate as $R_{\\text{ex, bile}}$. By definition, a rate of change of mass is the amount of mass, $dm$, transported over an infinitesimal time interval, $dt$.\n$$R_{\\text{ex, bile}} = \\frac{dm}{dt}$$\nThe principle of mass conservation for a solute carried by a flowing fluid stream states that the mass of solute passing a cross-section of the stream is the product of the solute concentration and the volume of fluid passing that cross-section.\n\nLet $C$ be the concentration of the solute (drug) in the fluid (bile), defined as mass per unit volume.\n$$C = \\frac{m}{V}$$\nTherefore, an infinitesimal amount of mass, $dm$, is contained within an infinitesimal volume of fluid, $dV$.\n$$dm = C \\cdot dV$$\nThe volumetric flow rate, $Q$, is the volume of fluid, $dV$, that flows past a point per unit time, $dt$.\n$$Q = \\frac{dV}{dt}$$\nTherefore, the infinitesimal volume element can be expressed as:\n$$dV = Q \\cdot dt$$\nNow, we substitute this expression for $dV$ into the equation for $dm$:\n$$dm = C \\cdot (Q \\cdot dt)$$\nTo find the rate of mass transport, we divide by $dt$:\n$$\\frac{dm}{dt} = \\frac{C \\cdot Q \\cdot dt}{dt}$$\n$$\\frac{dm}{dt} = C \\cdot Q$$\nApplying this general result to the specific context of biliary excretion, we substitute the specific variables for the drug concentration in bile, $C_{\\text{bile}}$, and the bile flow rate, $Q_{\\text{bile}}$. The biliary excretion rate, $R_{\\text{ex, bile}}$, is therefore given by the expression:\n$$R_{\\text{ex, bile}} = C_{\\text{bile}} \\cdot Q_{\\text{bile}}$$\nThis is the general expression for the rate at which drug mass leaves the liver via bile.\n\n**Part 2: Calculation of the Biliary Excretion Rate**\n\nWe now apply the derived expression using the provided numerical values.\nGiven:\n- $Q_{\\text{bile}} = 0.8\\,\\text{ml}/\\text{min}$\n- $C_{\\text{bile}} = 50\\,\\mu\\text{g}/\\text{ml}$\n\nSubstituting these values into the equation:\n$$R_{\\text{ex, bile}} = \\left(50\\,\\frac{\\mu\\text{g}}{\\text{ml}}\\right) \\cdot \\left(0.8\\,\\frac{\\text{ml}}{\\text{min}}\\right)$$\nThe units of volume ($\\text{ml}$) cancel, yielding the desired units of mass per time ($\\mu\\text{g}/\\text{min}$).\n$$R_{\\text{ex, bile}} = 50 \\cdot 0.8 \\, \\frac{\\mu\\text{g}}{\\text{min}} = 40 \\, \\frac{\\mu\\text{g}}{\\text{min}}$$\nThe problem explicitly requires the answer to be rounded to four significant figures. Therefore, the result $40$ must be expressed as $40.00$.\n$$R_{\\text{ex, bile}} = 40.00\\,\\mu\\text{g}/\\text{min}$$\n\n**Part 3: Mechanistic Interpretation**\n\nThe biliary excretion rate is the product of two physiological variables, $Q_{\\text{bile}}$ and $C_{\\text{bile}}$. Their determinants are distinct but interconnected.\n\n**Determinants of $Q_{\\text{bile}}$ (Bile Flow Rate):**\nBile flow is an osmotic process initiated by the active transport of solutes across the hepatocyte's canalicular membrane into the bile canaliculus. It is primarily composed of two components:\n1.  **Bile Salt-Dependent Flow**: This is the major driver of bile flow. Hepatocytes actively secrete bile acids (bile salts) into the canaliculus via ATP-dependent transporters, most notably the Bile Salt Export Pump (BSEP). The accumulation of these osmotically active solutes creates a high osmotic gradient that draws water and inorganic electrolytes ($\\text{Na}^+$, $\\text{Cl}^-$, etc.) from the hepatocyte and the paracellular space into the canaliculus, thus generating flow.\n2.  **Bile Salt-Independent Flow**: This component is driven by the secretion of other organic and inorganic substances, such as glutathione and bicarbonate ($\\text{HCO}_3^-$), by hepatocytes and cholangiocytes (the epithelial cells lining the bile ducts). Hormones like secretin can stimulate cholangiocytes to secrete $\\text{HCO}_3^-$, increasing the aqueous fraction of bile and thus $Q_{\\text{bile}}$.\n\n**Determinants of $C_{\\text{bile}}$ (Drug Concentration in Bile):**\nThe concentration of a drug in bile is the result of a multi-step transport process from blood to bile, which allows for concentration of the drug against a gradient.\n1.  **Hepatic Uptake**: The drug must first be taken up from the sinusoidal blood into the hepatocyte across its basolateral membrane. This is often mediated by carrier proteins like Organic Anion-Transporting Polypeptides (OATPs) or Organic Cation Transporters (OCTs).\n2.  **Canalicular Efflux**: The drug, or its metabolite, is then actively transported from the hepatocyte's cytoplasm into the bile canaliculus across the apical membrane. This efflux is the critical step for achieving a high $C_{\\text{bile}}$ and is mediated by ATP-binding cassette (ABC) transporters. Key transporters include P-glycoprotein (P-gp/MDR1), Multidrug Resistance-Associated Protein 2 (MRP2), and Breast Cancer Resistance Protein (BCRP). These pumps use the energy from ATP hydrolysis to move substrates against a large concentration gradient, resulting in $C_{\\text{bile}}$ values that can be hundreds or thousands of times higher than the plasma concentration.\n3.  **Drug Physicochemical Properties**: Efficient biliary excretion is favored for molecules that are substrates for these transporters. Typically, these are relatively large (Molecular Weight $> 300-500\\,\\text{Da}$), amphipathic molecules containing a polar group.\n4.  **Hepatic Metabolism**: Many drugs undergo Phase II metabolism (e.g., glucuronidation, sulfation) within the hepatocyte. This process adds a large, polar, negatively charged group to the drug molecule, creating a metabolite that is often an excellent substrate for transporters like MRP2 and is thus efficiently excreted into bile.\n\nIn summary, $Q_{\\text{bile}}$ is determined by the hepatocyte's secretory activity for bile salts and other osmolytes, while $C_{\\text{bile}}$ is determined by the efficiency of specific active transport systems that move the drug from blood to bile, often after metabolic transformation.", "answer": "$$\n\\boxed{40.00}\n$$", "id": "4940509"}, {"introduction": "Having established that biliary drug concentration is a key determinant of excretion, we now zoom in to the molecular level. This practice explores the active transporters, such as MRP2, that are responsible for pumping drugs from hepatocytes into bile, often against a steep concentration gradient. You will apply the classic Michaelis-Menten kinetic model to describe this saturable, carrier-mediated process, providing a quantitative understanding of how transporter efficiency changes with drug concentration and why biliary excretion is a capacity-limited pathway [@problem_id:4940548].", "problem": "A hepatocyte canalicular membrane expresses Multidrug Resistance-associated Protein 2 (MRP2), an adenosine triphosphate (ATP)-dependent efflux transporter that mediates biliary excretion of conjugated xenobiotics. In isolated canalicular membrane vesicles, the transporter-mediated efflux of a glucuronidated drug follows saturable carrier kinetics consistent with Michaelis–Menten behavior. Experimental characterization yields a maximal transport capacity of $V_{max} = 200$ pmol/min/mg protein and an apparent Michaelis constant of $K_m = 20\\,\\mu\\mathrm{M}$. During in vivo hepatic steady state, the free canalicular membrane concentration of the drug is estimated to be $C = 10\\,\\mu\\mathrm{M}$.\n\nUsing only the fundamental principles of saturable carrier-mediated transport and the standard steady-state form of Michaelis–Menten kinetics as the modeling base, compute the transporter-mediated biliary efflux rate per milligram of canalicular protein at the stated concentration. Round your answer to three significant figures. Express the final rate in pmol/min/mg protein.\n\nAdditionally, based on the relative magnitude of $C$ to $K_m$, explain whether the transporter is operating in a largely first-order (subsaturated), half-saturated, or near-zero-order (saturated) regime. Your final numeric answer should only be the calculated rate.", "solution": "The problem statement is first subjected to validation.\n\n**Step 1: Extract Givens**\n- **Model:** Saturable carrier kinetics consistent with Michaelis–Menten behavior.\n- **Transporter:** Multidrug Resistance-associated Protein 2 (MRP2) in hepatocyte canalicular membrane.\n- **Maximal transport capacity:** $V_{max} = 200$ pmol/min/mg protein.\n- **Apparent Michaelis constant:** $K_m = 20\\,\\mu\\mathrm{M}$.\n- **Free canalicular membrane concentration:** $C = 10\\,\\mu\\mathrm{M}$.\n- **Task 1:** Compute the transporter-mediated biliary efflux rate ($V$) at concentration $C$.\n- **Task 2:** Round the numerical answer to three significant figures.\n- **Task 3:** Explain the transporter's operating regime (first-order, half-saturated, or near-zero-order).\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is based on established principles of pharmacology and enzyme kinetics. The use of the Michaelis–Menten equation to model carrier-mediated transport is a standard and fundamental concept. The values provided for $V_{max}$, $K_m$, and $C$ are realistic for biological transport systems.\n- **Well-Posed:** The problem is well-posed. It provides all necessary parameters ($V_{max}$, $K_m$, $C$) to calculate the transport rate using the specified model. A unique solution exists.\n- **Objective:** The problem is stated using precise, objective scientific language. There are no subjective or ambiguous terms.\n\n**Step 3: Verdict and Action**\nThe problem is valid as it is scientifically sound, well-posed, and objective. A solution will be provided.\n\nThe efflux rate ($V$) for a transporter following Michaelis–Menten kinetics is described by the equation:\n$$V = \\frac{V_{max} \\cdot [S]}{K_m + [S]}$$\nIn this context, the substrate concentration $[S]$ is the free canalicular membrane concentration of the drug, denoted by $C$. Thus, the equation is:\n$$V = \\frac{V_{max} \\cdot C}{K_m + C}$$\nThe given parameters are:\n- Maximal transport capacity, $V_{max} = 200$ pmol/min/mg protein.\n- Michaelis constant, $K_m = 20\\,\\mu\\mathrm{M}$.\n- Drug concentration, $C = 10\\,\\mu\\mathrm{M}$.\n\nSubstituting these values into the Michaelis–Menten equation:\n$$V = \\frac{(200 \\, \\text{pmol/min/mg protein}) \\cdot (10\\,\\mu\\mathrm{M})}{(20\\,\\mu\\mathrm{M}) + (10\\,\\mu\\mathrm{M})}$$\nThe concentration units ($\\mu\\mathrm{M}$) in the numerator and denominator cancel out, yielding a rate in the same units as $V_{max}$.\n$$V = \\frac{2000}{30} \\, \\text{pmol/min/mg protein}$$\n$$V = \\frac{200}{3} \\, \\text{pmol/min/mg protein}$$\nCalculating the numerical value:\n$$V \\approx 66.666... \\, \\text{pmol/min/mg protein}$$\nAs instructed, rounding to three significant figures gives:\n$$V \\approx 66.7 \\, \\text{pmol/min/mg protein}$$\n\nNext, we determine the operating regime of the transporter. The regime is determined by the relationship between the substrate concentration $C$ and the Michaelis constant $K_m$.\n- **First-order (subsaturated) regime:** Occurs when $C \\ll K_m$. In this case, the rate $V$ is approximately proportional to $C$ ($V \\approx \\frac{V_{max}}{K_m}C$).\n- **Zero-order (saturated) regime:** Occurs when $C \\gg K_m$. The rate $V$ approaches its maximum, $V_{max}$, and is largely independent of $C$.\n- **Half-saturated point:** Occurs when $C = K_m$. At this specific concentration, the rate is exactly half of the maximum, $V = \\frac{1}{2}V_{max}$.\n\nIn this problem, $C = 10\\,\\mu\\mathrm{M}$ and $K_m = 20\\,\\mu\\mathrm{M}$. We can see that $C = \\frac{1}{2}K_m$. Since the concentration $C$ is less than $K_m$, the transporter is operating in the subsaturated region. The rate is still highly dependent on the concentration. While not in the strictly linear portion ($C \\ll K_m$), it is far from saturation ($C \\gg K_m$). The calculated rate $V = \\frac{1}{3}V_{max}$ confirms this, as it is substantially below the maximum rate $V_{max}$. Therefore, the transporter is operating in a largely first-order (subsaturated) regime. It is not at the specific half-saturation point ($C=K_m$) and is certainly not near zero-order saturation.", "answer": "$$\n\\boxed{66.7}\n$$", "id": "4940548"}, {"introduction": "The journey of a drug often continues even after it is secreted into the bile and enters the intestine. This final practice investigates the clinically significant phenomenon of enterohepatic recycling (EHR), where a portion of the excreted drug is reabsorbed from the gut back into systemic circulation. You will derive a model to see how EHR impacts a drug's total systemic clearance ($CL_T$) and overall exposure (AUC), and then apply this model to quantify the effect of a clinical intervention designed to interrupt this cycle [@problem_id:4940531].", "problem": "A single intravenous (IV) bolus dose of a drug is administered to an adult subject. The drug follows one-compartment, linear pharmacokinetics, with systemic elimination via two parallel routes: non-biliary processes (for example, renal excretion and metabolism) and biliary secretion into the intestine. Once in the intestine, a fraction of drug may be reabsorbed into the systemic circulation, a process known as enterohepatic recycling (EHR). Let the non-biliary clearance be $CL_{\\text{nb}}$ and the biliary clearance be $CL_{\\text{b}}$. Define the intestinal reabsorption efficiency as $r$, the fraction of drug entering the intestine that is reabsorbed rather than lost in the feces.\n\nUsing only fundamental definitions of clearance and mass balance, derive an expression for the Area Under the plasma concentration–time Curve (AUC) after the IV dose as a function of the dose $D$, $CL_{\\text{nb}}$, $CL_{\\text{b}}$, and $r$. Then, using your expression, compute the fractional change in AUC when activated charcoal is administered and reduces the intestinal reabsorption efficiency from $r = 0.7$ (without charcoal) to $r = 0.2$ (with charcoal). Take $CL_{\\text{nb}} = 7$ L/h and $CL_{\\text{b}} = 5$ L/h. Report the fractional change defined as\n$$\n\\frac{\\text{AUC}_{\\text{with charcoal}} - \\text{AUC}_{\\text{without charcoal}}}{\\text{AUC}_{\\text{without charcoal}}}\n$$\nas a unitless decimal. Round your answer to four significant figures.", "solution": "The problem will be validated by first extracting the given information and then assessing its scientific validity and structural integrity.\n\n### Step 1: Extract Givens\n-   A single intravenous (IV) bolus dose, $D$, of a drug is administered.\n-   The drug follows one-compartment, linear pharmacokinetics.\n-   Systemic elimination has two parallel routes: non-biliary processes and biliary secretion.\n-   Non-biliary clearance is $CL_{\\text{nb}}$.\n-   Biliary clearance is $CL_{\\text{b}}$.\n-   Enterohepatic recycling (EHR) occurs.\n-   The intestinal reabsorption efficiency, $r$, is the fraction of drug entering the intestine that is reabsorbed.\n-   First task: Derive an expression for the Area Under the plasma concentration–time Curve ($\\text{AUC}$) as a function of $D$, $CL_{\\text{nb}}$, $CL_{\\text{b}}$, and $r$.\n-   Second task: Compute the fractional change in $\\text{AUC}$ when $r$ changes due to activated charcoal.\n-   Condition without charcoal: $r = 0.7$.\n-   Condition with charcoal: $r = 0.2$.\n-   Given constant values: $CL_{\\text{nb}} = 7$ L/h, $CL_{\\text{b}} = 5$ L/h.\n-   The fractional change is defined as $\\frac{\\text{AUC}_{\\text{with charcoal}} - \\text{AUC}_{\\text{without charcoal}}}{\\text{AUC}_{\\text{without charcoal}}}$.\n-   The final numerical answer must be a unitless decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem describes a one-compartment pharmacokinetic model with parallel elimination pathways and enterohepatic recycling. This is a standard and well-established model in pharmacology and is based on fundamental principles of mass balance and clearance.\n-   **Well-Posed**: The problem is clearly stated and contains all necessary parameters ($D$, $CL_{\\text{nb}}$, $CL_{\\text{b}}$, $r$) to derive a unique expression for $\\text{AUC}$ and to calculate the subsequent fractional change. The model is specified as linear, which ensures that clearance values are constants.\n-   **Objective**: The problem is stated using precise, objective terminology common to the field of pharmacokinetics.\n-   **Completeness and Consistency**: The problem is self-contained. The provided values for clearances and reabsorption fractions are physiologically plausible. There are no contradictions in the given information.\n-   **Overall Assessment**: The problem is scientifically sound, well-posed, and free of any ambiguities or flaws.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\n### Solution Derivation\n\nThe analysis begins from the fundamental definition of total systemic clearance ($CL_{\\text{T}}$). For a drug administered via IV bolus, the total systemic clearance is defined as the dose ($D$) divided by the total area under the plasma concentration-time curve ($\\text{AUC}$):\n$$\nCL_{\\text{T}} = \\frac{D}{\\text{AUC}}\n$$\nThis can be rearranged to express $\\text{AUC}$ as:\n$$\n\\text{AUC} = \\frac{D}{CL_{\\text{T}}}\n$$\nThe core of the problem is to determine the correct expression for $CL_{\\text{T}}$ in the presence of enterohepatic recycling. Total clearance a measure of the body's efficiency in *irreversibly* removing a drug from the systemic circulation. We must apply mass balance principles to identify all pathways of irreversible drug loss.\n\nLet $C(t)$ be the plasma drug concentration at time $t$. The drug leaves the systemic circulation (the central compartment) via two routes:\n1.  Non-biliary elimination (e.g., renal excretion, metabolism), at a rate of $CL_{\\text{nb}} \\times C(t)$. This represents an irreversible loss from the body.\n2.  Biliary secretion into the intestine, at a rate of $CL_{\\text{b}} \\times C(t)$. This is not an immediate irreversible loss, as some drug can be reabsorbed.\n\nThe drug secreted into the intestine via the bile follows one of two fates:\n1.  A fraction, $r$, is reabsorbed back into the systemic circulation. This is the recycling pathway. The rate at which the drug amount returns to the systemic circulation from the intestine is $r \\times (\\text{rate of biliary secretion}) = r \\times CL_{\\text{b}} \\times C(t)$.\n2.  The remaining fraction, $(1-r)$, is not reabsorbed and is eventually excreted in the feces. This represents an irreversible loss from the body. The rate of this fecal excretion is $(1-r) \\times (\\text{rate of biliary secretion}) = (1-r) \\times CL_{\\text{b}} \\times C(t)$.\n\nThe total rate of irreversible drug removal from the system is the sum of the rates of all permanent elimination pathways:\n$$\n\\text{Rate}_{\\text{total removal}} = (\\text{Rate of non-biliary elimination}) + (\\text{Rate of fecal excretion})\n$$\nSubstituting the expressions for these rates:\n$$\n\\text{Rate}_{\\text{total removal}} = [CL_{\\text{nb}} \\times C(t)] + [(1-r) \\times CL_{\\text{b}} \\times C(t)]\n$$\nFactoring out $C(t)$:\n$$\n\\text{Rate}_{\\text{total removal}} = [CL_{\\text{nb}} + (1-r)CL_{\\text{b}}] \\times C(t)\n$$\nTotal clearance, $CL_{\\text{T}}$, is defined as the proportionality constant relating the total rate of removal to the plasma concentration:\n$$\nCL_{\\text{T}} = \\frac{\\text{Rate}_{\\text{total removal}}}{C(t)} = CL_{\\text{nb}} + (1-r)CL_{\\text{b}}\n$$\nThis expression represents the effective total systemic clearance for a drug undergoing enterohepatic recycling. Substituting this into the equation for $\\text{AUC}$ gives the desired expression:\n$$\n\\text{AUC} = \\frac{D}{CL_{\\text{nb}} + (1-r)CL_{\\text{b}}}\n$$\n\n### Calculation of Fractional Change in AUC\n\nNow, we use this derived expression to calculate the fractional change in $\\text{AUC}$ when activated charcoal is administered. Let $\\text{AUC}_{\\text{without}}$ and $\\text{AUC}_{\\text{with}}$ be the $\\text{AUC}$ values without and with charcoal, respectively. The corresponding reabsorption efficiencies are $r_1=0.7$ and $r_2=0.2$.\n\nUsing the derived formula:\n$$\n\\text{AUC}_{\\text{without}} = \\frac{D}{CL_{\\text{nb}} + (1-r_1)CL_{\\text{b}}}\n$$\n$$\n\\text{AUC}_{\\text{with}} = \\frac{D}{CL_{\\text{nb}} + (1-r_2)CL_{\\text{b}}}\n$$\nThe fractional change is given by:\n$$\n\\text{Fractional Change} = \\frac{\\text{AUC}_{\\text{with}} - \\text{AUC}_{\\text{without}}}{\\text{AUC}_{\\text{without}}} = \\frac{\\text{AUC}_{\\text{with}}}{\\text{AUC}_{\\text{without}}} - 1\n$$\nLet's compute the ratio $\\frac{\\text{AUC}_{\\text{with}}}{\\text{AUC}_{\\text{without}}}$:\n$$\n\\frac{\\text{AUC}_{\\text{with}}}{\\text{AUC}_{\\text{without}}} = \\frac{\\frac{D}{CL_{\\text{nb}} + (1-r_2)CL_{\\text{b}}}}{\\frac{D}{CL_{\\text{nb}} + (1-r_1)CL_{\\text{b}}}} = \\frac{CL_{\\text{nb}} + (1-r_1)CL_{\\text{b}}}{CL_{\\text{nb}} + (1-r_2)CL_{\\text{b}}}\n$$\nNow, we substitute the given numerical values: $CL_{\\text{nb}} = 7$ L/h, $CL_{\\text{b}} = 5$ L/h, $r_1=0.7$, and $r_2=0.2$.\n$$\n\\frac{\\text{AUC}_{\\text{with}}}{\\text{AUC}_{\\text{without}}} = \\frac{7 + (1-0.7) \\times 5}{7 + (1-0.2) \\times 5} = \\frac{7 + (0.3) \\times 5}{7 + (0.8) \\times 5} = \\frac{7 + 1.5}{7 + 4.0} = \\frac{8.5}{11.0}\n$$\nThe fractional change is then:\n$$\n\\text{Fractional Change} = \\frac{8.5}{11.0} - 1 = \\frac{8.5 - 11.0}{11.0} = \\frac{-2.5}{11.0}\n$$\nCalculating the decimal value:\n$$\n\\text{Fractional Change} = -0.2272727...\n$$\nRounding to four significant figures, the result is $-0.2273$. The negative sign indicates a decrease in $\\text{AUC}$, which is expected as administering charcoal enhances the effective clearance of the drug by preventing its reabsorption.", "answer": "$$\n\\boxed{-0.2273}\n$$", "id": "4940531"}]}